CSRxP: ETHIC Act & Skinny Labels, Big Savings Act
Jul 30, 2026
Two bipartisan solutions — the ETHIC Act and Skinny Labels, Big Savings Act… Read More
© 2026 CSRXP- All Rights Reserved
Resources
CSRxP: Margin Analysis
Jul 27, 2026
SEC filings show that brand name pharmaceutical manufacturers’ profit… Read More
CSRxP: Senate HELP Fact Sheet
Jul 21, 2026
Bipartisan, Market-Based Solution Would Streamline Drug Approval Process and… Read More
CSRxP: E&C Markup Fact Sheet
Jul 20, 2026
How Congress Can Lower Drug Prices, Boost Competition Bipartisan,… Read More
CSRxP: HELP Preview Biosimilar Fact Sheet
Jun 16, 2026
Several bipartisan, market-based solutions that would help foster greater… Read More
CSRxP: Myth v. Fact
Jun 12, 2026
How Congress Can Lower Drug Prices, Boost Competition Trio of Bipartisan… Read More
CSRxP: Myth vs. Fact
Jun 11, 2026
Brand name drug manufacturers game the patent system and drug approval process… Read More
CSRxP: ETHIC & Skinny Labels
Jun 1, 2026
Two bipartisan solutions — the ETHIC Act and Skinny Labels… Read More
CSRxP: Innovation
May 29, 2026
For far too long, Big Pharma has used the false excuse that research and… Read More
CSRxP: Statement for the Record
Feb 10, 2026
Committee Chairman Guthrie, Committee Ranking Member Pallone, Subcommittee… Read More
CSRxP: Affordability
Jan 20, 2026
Big Pharma’s egregious pricing and anti-competitive practices are… Read More
CSRxP: Margin Analysis
Jan 13, 2026
Pharmaceutical manufacturers’ profit margins are 10 times larger than other… Read More